RepoTrialH2020 Profile Banner
REPO-TRIAL H2020 Profile
REPO-TRIAL H2020

@RepoTrialH2020

Followers
103
Following
292
Media
40
Statuses
95

REPO-TRIAL develops a computerized (in silico) approach to optimise the efficacy and precision of drug repurposing trials. Follow the project's progresss here!

Europe
Joined March 2018
Don't wanna be here? Send us removal request.
@RepoTrialH2020
REPO-TRIAL H2020
2 years
📽️5️⃣👉 https://t.co/28K1zlXZTo Last but not least – the final video of the #RepoTrial video series! 🎞 Learn more about #patents –understanding their nuances and essential considerations when dealing with patents. 🧐 Don't miss this expert advice from Dr. Herman Mucke!
0
2
6
@RepoTrialH2020
REPO-TRIAL H2020
2 years
📽️4️⃣👉 https://t.co/8KDS9Kuh7d The #RepoTrial video series is still going! 🎞 Watch the newest addition, as @cristiannogals shares insights into #applied #bioinformatics and #diagnostics. 💻🧪🔬
0
2
5
@RepoTrialH2020
REPO-TRIAL H2020
2 years
📽️3️⃣👉 https://t.co/4vhPh5eGE5 Watch the latest addition to the #RepoTrial video series! 🎞 Join the scientific coordinator @hhhwschmidt, as he discusses the clinical validation of in silico trial #prediction. Don’t miss out on this intriguing talk!
0
3
6
@RepoTrialH2020
REPO-TRIAL H2020
2 years
📽️2⃣👉 https://t.co/MKcryiwwMJ The #RepoTrial video series continues! Watch the latest video on #YouTube to explore the pre-clinical validation of in-silico therapeutic predictions with Dr. @AnaicasasU!🌐 Learn more about the future of medical innovation! 🚀
0
2
5
@REPO4EU
REPO4EU
2 years
Hello Australia & New Zealand! 👋 You can now register for our FREE hybrid event in #Melbourne on 1 Feb, where we'll be hosting several short talks covering all aspects of #DrugRepurposing — and there'll be plenty of time for networking 😎 Sign up here ⤵️ https://t.co/1k0LK3XgTM
0
1
3
@concentris_EU
concentris
2 years
concentris wishes everyone the warmest #SeasonsGreetings! 🌟 Big thanks to our dedicated team and also to our valued project partners for their trust and contributions. Wishing everyone a joyful holiday season! 🌟 #Teamwork #HappyHolidays
0
6
12
@Feature_Cloud
FeatureCloud
2 years
#Partea is an intuitive web #App that elevates #TimeToEvent analyses for collaborating clinics🏥🏥🏥 to another level! Read this paper by @julian_spaeth et al. about #privacy-aware🔐#federated implementations of the most used algorithms, e.g. #survival.🩺📈 https://t.co/xN5g55HLYR
0
4
7
@REPO4EU
REPO4EU
2 years
🤩 We're very proud of @ferdelgadoch from @unihh, who introduced #REPO4EU's innovative work at @denbiOffice's #BioHackDE23. Thank you for being a key player in our mission to implement #AI tools in #DrugRepurposing 💊 👀 Spot Fernando right at the front of this group photo!
0
3
8
@RepoTrialH2020
REPO-TRIAL H2020
2 years
📽️1⃣👉 https://t.co/VbR50N17A4 Today we kick off the final #RepoTrial video series: Lean back, relax, and enjoy free lectures about #SystemsMedicine and #DrugRepurposing! The scientific coordinator @hhhwschmidt takes the lead by presenting the project overview & main outcomes.
0
3
6
@Feature_Cloud
FeatureCloud
2 years
Aligned with #FeatureCloud’s achievement to create a platform for secure🔐#decentralized data analysis between collaborating clinics across the globe🌎, @achauschild et al. evaluated the efficacy of #federated #RandomForests for medical #PredictiveModels⚕️ https://t.co/CjHEm8Lgdd
0
5
9
@Feature_Cloud
FeatureCloud
2 years
👨‍👩‍👧‍👦In multi-cohort #MachineLearning studies💻, it is critical to discern effects that are reproducible across #cohorts & those that are cohort-specific. This new #federated Multi-Task Learning (#MTL) approach facilitates this differentiation. #DataSHIELD https://t.co/avoLcaNLLX
0
7
10
@REPO4EU
REPO4EU
2 years
After a 7-hour session packed with fruitful discussions on #DrugRepurposing, hearing exciting updates from the #REPO4EU consortium, we wrap up the second day of our 3rd General Assembly with a group photo 🙌 Thanks to all our partners who joined us in-person in Stockholm! 🇸🇪
0
1
6
@REPO4EU
REPO4EU
2 years
#ScienceFridays🔬 ‘Polypharmacology guided drug repositioning approach for SARS-CoV2’ ✍️ by researchers from @AcSIR_India and @CSIR_NEIST Research paper of the week selected via our #DrugRepurposing Research Collection on @Science_Open 👇 https://t.co/kcEPm1stGC
1
3
4
@cosybio_UHH
CoSy.Bio
2 years
🎉 Congratulations to our own @ferdelgadoch who won the #YoungInvestigatorAward at the #RExPO23 conference last week🏆. Your hard work and dedication truly paid off. We couldn't be prouder! @REPO4EU @janbaumbach
1
3
14
@aisym4med
AISym4MED - Health Horizon Europe Project
2 years
Are you a #student or a #youngprofessional from the #STEM area? Do you want to know more about #GenerativeAI? @aisym4med has the right course for you! 📢 Ensure your spot by subscribing directly through the dedicated FORM on our website: https://t.co/BZ7ypTryKA ! 🔥
0
8
8
@concentris_EU
concentris
2 years
🌍Today is #WorldScienceDay. 🔬At concentris, we're dedicated to supporting #Science & #Health innovation. Science has the power to transform societies & address global challenges. Let's celebrate scientists and researchers in making our world a better place.
0
8
11
@gcb2024
gcb2025
3 years
The second day of the #gcb2023 began with a captivating keynote by Joseph Loscalzo from Harvard Medical School about the ‘Network Medicine and #Bioinformatics: An Alliance in Search of Pathobiological Mechanism and Drug Discovery‘. @DECHEMA @janbaumbach
0
1
12
@RepoTrialH2020
REPO-TRIAL H2020
3 years
🧬#SystemsMedicine today⚕️: This #Review discusses #MolecularNetworks (types of data, analytical methods, ways to validate them). Categorizing diseases by organs or symptoms is the past - deciphering disease mechanisms is the future! @hhhwschmidt @REPO4EU https://t.co/R9mOHwAw2b
0
1
6
@RepoTrialH2020
REPO-TRIAL H2020
3 years
Interested in #DrugRepurposing & its potential for #MarketAccess in Europe? Listen to Kolja Adamczyk (NLO | European #patent and #trademark attorneys) to learn about opportunities in this field. @REPO4EU @HorizonEU @hhhwschmidt @hmpharmacon @LangeLiesbeth https://t.co/YoJuAQb44G
0
4
5